These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 913062)

  • 41. Vitamin D compounds in cows' milk.
    Reeve LE; Jorgensen NA; DeLuca HF
    J Nutr; 1982 Apr; 112(4):667-72. PubMed ID: 6279806
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Production of C-24- and C-23-oxidized metabolites of 1,25-dihydroxycholecalciferol by cultured kidney cells (LLC PK1) and their presence in kidney in vivo.
    Napoli JL; Martin CA
    Biochem J; 1984 May; 219(3):713-7. PubMed ID: 6547601
    [TBL] [Abstract][Full Text] [Related]  

  • 43. History of vitamin D treatment of renal osteodystrophy.
    Morii H; Ishimura E; Inoue T; Tabata T; Morita A; Nishii Y; Fukushima M
    Am J Nephrol; 1997; 17(3-4):382-6. PubMed ID: 9189258
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vitamin D metabolites and their relationship to azotaemic osteodystrophy.
    Mason RS; Lissner D; Wilkinson M; Posen S
    Clin Endocrinol (Oxf); 1980 Oct; 13(4):375-85. PubMed ID: 7438480
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The metabolism of cholecalciferol in the liver of Japanese quail (Coturnix coturnix japonica) with particular reference to the effects of oestrogen.
    Nicholson RA; Akhtar M; Taylor TG
    Biochem J; 1979 Sep; 182(3):745-50. PubMed ID: 229826
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatic metabolism of vitamin D in chronic renal failure.
    Farrington K; Skinner RK; Varghese Z; Moorhead JF
    Lancet; 1979 Feb; 1(8111):321. PubMed ID: 84969
    [No Abstract]   [Full Text] [Related]  

  • 47. Biliary excretion of amphetamine and methamphetamine in the rat.
    Caldwell J; Dring LG; Williams RT
    Biochem J; 1972 Aug; 129(1):25-9. PubMed ID: 4646778
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Activation of vitamin D 3 and the mode of action of 1,25-hydroxycholecalciferol and 24,25-hydroxycholecalciferol].
    Kolb E
    Z Gesamte Inn Med; 1976 Aug; 31(15):561-7. PubMed ID: 186964
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Improved cholecalciferol nutrition in rats is noncalcemic, suppresses parathyroid hormone and increases responsiveness to 1, 25-dihydroxycholecalciferol.
    Vieth R; Milojevic S; Peltekova V
    J Nutr; 2000 Mar; 130(3):578-84. PubMed ID: 10702588
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metabolism of orally administered [3H]ergocalciferol and [3H]cholecalciferol by dairy calves.
    Sommerfeldt JL; Napoli JL; Littledike ET; Beitz DC; Horst RL
    J Nutr; 1983 Dec; 113(12):2595-600. PubMed ID: 6317829
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetics of 5,6-trans-25-hydroxycholecalciferol, a synthetic analogue of vitamin D3, in man.
    Offermann G; Schaefer K; Grigoleit HG; Dittmar F
    Eur J Clin Pharmacol; 1975 Apr; 8(3-4):255-60. PubMed ID: 1233221
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The metabolism of a physiological dose of radioactive cholecalciferol (vitamin D3) to its hydroxylated metabolites in man.
    Stanbury SW; Mawer EB
    Clin Sci (Lond); 1980 Jun; 58(6):523-35. PubMed ID: 6253118
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro synthesis of 1 alpha,25-dihydroxycholecalciferol and 24,25-dihydroxycholecalciferol by isolated calvarial cells.
    Turner RT; Puzas JE; Forte MD; Lester GE; Gray TK; Howard GA; Baylink DJ
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):5720-4. PubMed ID: 6934505
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The parotid gland: a new target organ for vitamin D action.
    Goodwin D; Noff D; Edelstein S
    Biochim Biophys Acta; 1978 Mar; 539(2):249-52. PubMed ID: 204359
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metabolism of vitamin D. A new cholecalciferol metabolite, involving loss of hydrogen at C-1, in chick intestinal nuclei.
    Lawson DE; Wilson PW; Kodicek E
    Biochem J; 1969 Nov; 115(2):269-77. PubMed ID: 4314119
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of 1 alpha-hydroxycholecalciferol and 25-hydroxycholecalciferol in the treatment of renal osteodystrophy: greater effect of 25-hydroxycholecalciferol on bone mineralization.
    Fournier A; Bordier P; Gueris J; Sebert JL; Marie P; Ferrière C; Bedrossian J; DeLuca HF
    Kidney Int; 1979 Feb; 15(2):196-204. PubMed ID: 513484
    [No Abstract]   [Full Text] [Related]  

  • 57. Biologic effects of 1,25-dihydroxycholecalciferol (a highly active vitamin D metabolite) in acutely uremic rats.
    Wong RG; Norman AW; Reddy CR; Coburn JW
    J Clin Invest; 1972 May; 51(5):1287-91. PubMed ID: 4341503
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Biological activity of 1alpha-hydroxycholecalciferol (1). Effect on intestine and bone in rats (author's transl)].
    Kawashima H; Hoshina K; Saitoh N; Okamiya Y; Hashimoto Y; Ishimoto S; Noguchi T; Orimo H
    Nihon Yakurigaku Zasshi; 1978 Mar; 74(2):267-83. PubMed ID: 658840
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Control of 25-hydroxycholecalciferol metabolism by parathyroid glands.
    Garabedian M; Holick MF; Deluca HF; Boyle IT
    Proc Natl Acad Sci U S A; 1972 Jul; 69(7):1673-6. PubMed ID: 4340153
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Metabolic consequences of oral administration of 24,25-dihydroxycholecalciferol to uremic dogs.
    Canterbury JM; Gavellas G; Bourgoignie JJ; Reiss E
    J Clin Invest; 1980 Mar; 65(3):571-6. PubMed ID: 7354130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.